Acute Myeloid Leukemia — Use of Ribavirin and Low Dose Ara-C to Treat Acute Myeloid Leukemia
Citation(s)
A Phase I/II Study of Ribavirin and Low-dose Cytarabine Arabinoside (Ara-C) in Acute Myeloid Leukemia (AML) M4 and M5 Subtypes, and AML With High eIF4E Expression